08212017Headline:

St. Petersburg, Florida

HomeFloridaSt. Petersburg

Email Bob Carroll Bob Carroll on LinkedIn Bob Carroll on Twitter Bob Carroll on Facebook
Bob Carroll
Bob Carroll
Contributor •

Strattera Linked To Suicide Risk

Comments Off

The FDA is warning patients and doctors about a new risk associated with Strattera. Strattera is used to treat a condition called Attention-Deficit with Hyperactivity Disorder (ADHD) in children, teens, and adults. Suicidal thoughts or actions: Strattera may increase thoughts of suicide or suicide attempts in infrequent cases. Call you doctor right away if you become irritable or anxious or have other mood changes, or if you have thoughts of suicide.

The FDA is warning patients and doctors about a new risk associated with Strattera. The Patient Information Sheet posted by the FDA regarding Atomoxetine (marketed as Strattera) contains the following information. Strattera is used to treat a condition called Attention-Deficit with Hyperactivity Disorder (ADHD) in children, teens, and adults. Suicidal thoughts or actions: Strattera may increase thoughts of suicide or suicide attempts in infrequent cases. Call you doctor right away if you become irritable or anxious or have other mood changes, or if you have thoughts of suicide. [Just how this instuction will be applied by children or teenagers is left to our imagination.]

Strattera has not been studied in children under 6 years old.